Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Hampson Industries, Bezant, Tangent Comms...

Thu, 26th Nov 2009 14:45

Aerospace and engineering group Hampson Industries reported a 32% slump in first half profit before tax to £11m on revenue down 12% to £97m."Although the immediate outlook for our core markets remains uncertain, present customer indications and the scale of new work in the pipeline all point to a gradual increase in the release of new orders in the months ahead," said chairman Chris Geoghegan."Tooling order books have increased in September and October and with leading indicators now generally more encouraging, we are cautiously optimistic of seeing further order strengthening over the second half."Gold and copper explorer Bezant lost £1.77m in the year ended 30 June 2009 due to its exploration activities in the Philippines and Tanzania.Executive chairman Gerry Nealon says Bezant's flagship Mankayan project in the Philippines has the potential to become a world class mine. News on future plans are expected early next yearPre-tax profit fell to £189,000 at Tangent Communications in the six months to 31 August, down from £500,000 in 2008, although the direct marketing firm says the outlook for the rest of the year is in line with management's expectations."The increased cost base from our recent acquisitions had a negative impact on the overall profitability, although we expect this investment in skills to deliver future growth in higher margin parts of the business," said the group.Stem cell developer ReNeuron narrowed losses from £3m to £2m in the year to September and said it has secured a two-year equity funding facility up to £5m from its joint broker, Matrix Corporate Capital.The AIM-listed firm said it remains confident of meeting the remaining requirements for its pioneering ReN001 therapy for stroke to allow initiation of a first-in-man clinical trial early next year.Alexon Group, the ladies clothing retailer, reports total sales for the 16 weeks to 21 November dropped 14% on a like for like basis.The firm blamed a 16.9% slump in sales for the first 8 weeks of the period on its decision to make fewer summer reductions, although they fell just 8.7% in the final 8 weeks. "Looking ahead, the board anticipates that the current price competitive environment will continue through the critical Christmas trading period and into the January sales. This is likely to adversely affect margins but the company's financial position remains secure," it said.
More News
14 Jul 2021 15:15

IN BRIEF: ReNeuron hires Swiss exec as senior independent director

IN BRIEF: ReNeuron hires Swiss exec as senior independent director

Read more
8 Jul 2021 11:38

TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter

TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter

Read more
1 Jul 2021 17:05

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

Read more
9 Jun 2021 17:47

TRADING UPDATES: Ted Baker results in line; Gulf Marine raises cash

TRADING UPDATES: Ted Baker results in line; Gulf Marine raises cash

Read more
20 May 2021 20:23

TRADING UPDATES: Amigo wants suspension lift; Young's sinks to loss

TRADING UPDATES: Amigo wants suspension lift; Young's sinks to loss

Read more
19 Mar 2021 16:43

ReNeuron signs new collaboration agreements

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced the signing of new collaboration agreements with a major pharmaceutical company and leading academic institutions in the UK and mainland Europe on Friday.

Read more
19 Mar 2021 11:34

ReNeuron inks commercial collaboration deals for exosome platform

ReNeuron inks commercial collaboration deals for exosome platform

Read more
19 Mar 2021 11:20

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

Read more
12 Mar 2021 15:39

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

Read more
27 Jan 2021 13:43

IN BRIEF: Schroder UK Public Private Sells Basket Of Seven Assets

IN BRIEF: Schroder UK Public Private Sells Basket Of Seven Assets

Read more
15 Jan 2021 15:29

IN BRIEF: ReNeuron Treats First Patient In Extended Retinal Study

IN BRIEF: ReNeuron Treats First Patient In Extended Retinal Study

Read more
17 Dec 2020 22:00

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

Read more
11 Dec 2020 14:26

ReNeuron Conditionally Raises GBP17.5 Million Through Placing

ReNeuron Conditionally Raises GBP17.5 Million Through Placing

Read more
24 Nov 2020 14:41

IN BRIEF: ReNeuron Interim Loss Widens; Raises GBP15 Million

IN BRIEF: ReNeuron Interim Loss Widens; Raises GBP15 Million

Read more
23 Nov 2020 19:09

UK TRADING UPDATE SUMMARY: ReNeuron Plans Fundraise To Support Study

UK TRADING UPDATE SUMMARY: ReNeuron Plans Fundraise To Support Study

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.